Noáin, Spain · Founded 2019 · Privately Held (backing)
Developer of postbiotic therapeutics designed to support metabolic health in conditions related to glucose regulation, weight management, and cardiovascular function. Genbioma is based in Noáin, Spain and was founded in 2019. Its last reported valuation was $1.9 million in Jan 2021. It has raised $1.5 million.
Last reported valuation
$1.9M
Oct 2026
Priced at
—
Total raised
$1.5M
Last round
—
Cap table — not yet on record
Genbioma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Genbioma with a free account
·Watch Genbioma: the Monday email on marks, rounds and moves
